Similarly, SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) has been shown to upregulate in patients with IPF, increasing their susceptibility to COVID-19 [15,19]. Here, ACE2 is linked to idiopathic pulmonary fibrosis.